Fundraising Fox
/People
Sign in

Tal Zaks

Investor

Partner at OrbiMed · Board director at Averna Therapeutics · Board director at Convergent Therapeutics

Newton, Massachusetts, United States

Find your path to Tal

772 people in our graph can introduce you to Tal.

Each arrow is one introduction. Sign up to fill in the first one.

Ask Mathias Frederiksen to introduce you to Tal

You →Mathias · together at Averna Therapeutics (2024–2026) →Tal

Ask Jamie Chen to introduce you to Tal

You →Jamie · 2 people · together at Averna Therapeutics →Tal

Ask Sam Okafor to introduce you to Tal

You →Sam · together at Cephalon →Tal

Sign up to find every way you can get introduced to Tal

  • Your email: the people you already email who know Tal
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Tal
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Sign up with GoogleAlready have an account? Log in

About

Partner at OrbiMed holding both M.D. and Ph.D. degrees.

Board director at Averna Therapeutics

Intro paths

→

In turn, Tal can intro founders to Averna Therapeutics's investors below.

Averna Therapeutics's investors · 4

Deep InsightTel AvivDelos CapitalCambridgeNovartis Venture FundBasel · $5M – $25M checks · since 2024OrbiMedNew York · $1M – $75M checks · since 2024

Board director at Convergent Therapeutics

Intro paths

→

In turn, Tal can intro founders to Convergent Therapeutics's investors below.

Convergent Therapeutics's investors · 3

InvusNew York · since 2023OrbiMedNew York · $1M – $75M checks · since 2023RA CapitalBoston · since 2023

Co-founders at Convergent Therapeutics

PKPhilip Kantoff
Philip KantoffChief Executive Officer, Co-Founder
NBNeil Bander
Neil BanderSenior Scientific Advisor, Co-Founder

Experience

  1. OrbiMedPartner, Private Equitycurrent2022 — presentBoston, Massachusetts, United States
  2. OrbiMedVenture Partner2021 — 2022
  3. Averna TherapeuticsExecutive Chairmancurrent2024 — presentBoston, Massachusetts, United States
  4. Curevo VaccineNon Executive Directorcurrent2025 — present
  5. Minervax ApSNon Executive Directorcurrent2023 — presentDenmark
  6. Convergent Therapeutics, Inc.Non Executive Directorcurrent2023 — presentMassachusetts, United States
  7. iECURE, inc.Non Executive Directorcurrent2022 — presentPhiladelphia, Pennsylvania, United States
  8. Teva PharmaceuticalsNon Executive Directorcurrent2021 — present
  9. University of PennsylvaniaAdjunct Associate Professor of Medicine, School of Medicinecurrent2004 — present
  10. PIC TherapeuticsNon Executive Director2022 — 2025Massachusetts, United States
  11. Adaptimmune USNon Executive Director2016 — 2023
  12. Moderna TherapeuticsChief Medical Officer2015 — 2021Cambridge, MA
  13. SanofiSVP, Head of Sanofi Oncology2013 — 2015Cambridge, MA
  14. SanofiVP, Head of Development, Oncology Division2010 — 2014Cambridge, MA
  15. VA Medical CenterAttending, Medical Oncology2008 — 2010
  16. CephalonVP, Clinical Research Oncology2008 — 2010
  17. GlaxoSmithKlineDirector, clinical development and translational medicine2004 — 2008
  18. University of Pennsylvania School of MedicineClinical Fellow2002 — 2004
  19. Temple University HospitalResident1999 — 2002
  20. National Cancer InstitutePostdoctoral fellow1996 — 1999

Deals · 1

Curevo, Inc.Board seat

via OrbiMed · filed Mar 2025 · $84.8M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Per SEC Form D filings.

Colleagues at OrbiMed

Alexander M. Cooper
Investor at OrbiMed
Anat Nursella
Venture Partner at OrbiMed
Andrew P. Kanarek, CFA, CIPM
Investor at OrbiMed
Ankesh Bhansali
Investor at OrbiMed
Arun Sadhanandham
Investor at OrbiMed
Bill Moschella
Venture Partner at OrbiMed
Bob Smith
Investor at OrbiMed
Brendan Weber
Principal at OrbiMed

Frequently asked questions

Who is Tal Zaks?
Partner at OrbiMed holding both M.D. and Ph.D. degrees.
Where does Tal Zaks work?
Tal Zaks is Partner at OrbiMed and Board director at Averna Therapeutics and Board director at Convergent Therapeutics.
What boards does Tal Zaks sit on?
Tal Zaks holds tracked board seats at Convergent Therapeutics, Curevo, Inc..
Where did Tal Zaks go to school?
Tal Zaks studied at University of Pennsylvania School of Medicine (Clinical Fellow, Hematology-Oncology); Ben-Gurion University of the Negev (PhD, Tumor Immunology); Ben-Gurion University of the Negev (MD).

Same school

Shared employers